Remove Avalon Remove Capital Remove Companies Remove Technology
article thumbnail

Avalon Ventures Gets Commitments Of $103M In New, $300M Fund

socalTECH

La Jolla-based venture capital investor Avalon Ventures has just received a $103M commitment to a new, $300M fund, according to a regulatory filing by the firm. Avalon invests in both life sciences and technology companies, and invests in seed an dearly stage companies. READ MORE>>.

Avalon 100
article thumbnail

Avalon Ventures Closes $200M Fund

socalTECH

San Diego-based Avalon Ventures , a venture capital firm focused on early stage high tech, digital media, and life sciences firms, said today that it has closed on $200M in capital commitments for its latest fund. Avalon said that the fund, Avalon Ventures IX, LP, is the ninth and largest fund for the company.

Avalon 140
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Avalon Leads $18M in Early Funding for Cancer Immunotherapy Startup

Xconomy

[ Note: The headline has been corrected to better describe the company’s type of funding. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups). 9/27/16, 2:09 p.m. Bregua Corp.,

Avalon 40
article thumbnail

Synthorx Raises $10M

socalTECH

San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures. RA Capital Management's Andrew Levin joins the company's board with the funding.

Avalon 100
article thumbnail

Avelas Biosciences Raises $6.85M

socalTECH

San Diego-based Avelas Biosciences announced today that it has raised $6.85M in a Series B funding round, for the company''s technology for illuminating cancer cells. The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor.

Avalon 138
article thumbnail

Avelas Biosciences Finds $7.4M

socalTECH

The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. The technology behind the Avelas product is based on research conducted at UC San Diego. in a Series B funding. READ MORE>>.

Avalon 147
article thumbnail

Enlibrium Finds $15M For Cancer Drugs

socalTECH

The funding was led by Avalon Ventures and TPG Biotech, and also included Correlation Ventures and Osage University Partners. The company was founded by Dr. Michael Jung and Dr. Michael Jung and Dr. Richard Pietras, both of whom are professors at the University of California, Los Angeles (UCLA). READ MORE>>.

UCLA 100